ASMB
What one share of Assembly Biosciences holds
Pharmaceutical Preparations
We are a biotechnology company developing innovative therapeutics targeting serious viral diseases with the potential to improve the lives of patients worldwide.
Assembly Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.57 |
|---|---|
| Profit | −$0.00 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$2.36 |
| Cash and investments | $1.63 |
| Book value | $15.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.00 | −$2.57 | $0.01 | −$2.03 | — | $4.63 |
| 2017 | $0.51 | −$2.41 | $0.05 | $0.06 | — | $5.62 |
| 2018 | $0.65 | −$3.98 | $0.01 | −$2.86 | — | $8.26 |
| 2019 | $0.61 | −$3.72 | $0.06 | −$3.26 | — | $8.39 |
| 2020 | $2.23 | −$1.75 | $0.01 | −$1.79 | — | $7.07 |
| 2021 | $0.14 | −$3.00 | $0.07 | −$2.23 | — | $3.51 |
| 2022 | $0.00 | −$23.08 | $0.03 | −$20.96 | — | $20.29 |
| 2023 | $1.56 | −$13.38 | $0.06 | $4.91 | — | $7.50 |
| 2024 | $4.75 | −$6.69 | $0.00 | −$8.52 | — | $4.47 |
| 2025 | $6.45 | −$0.55 | $0.01 | −$3.67 | — | $13.04 |